Cargando…

Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme

BACKGROUND: Glioblastoma multiforme (GBM) is one of the most malignant tumors in brain with high morbidity and mortality. Mitophagy plays a significant role in carcinogenesis, metastasis, and invasion. In our study, we aim to construct a mitophagy-related risk model to predict prognosis in GBM. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jinghua, Qiu, Xinqi, Huang, Jiayu, Zhuo, Zewei, Chen, Hao, Zeng, Ruijie, Wu, Huihuan, Guo, Kehang, Yang, Qi, Ye, Huiling, Huang, Wei, Luo, Yujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190154/ https://www.ncbi.nlm.nih.gov/pubmed/35692054 http://dx.doi.org/10.1186/s12885-022-09707-w

Ejemplares similares

Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
por: Chen, Hao, et al.
Publicado: (2021)

Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
por: Zeng, Ruijie, et al.
Publicado: (2021)

Current therapy option for necrotizing enterocolitis: Practicalities and challenge
por: Wu, Huihuan, et al.
Publicado: (2022)

Investigating regulatory patterns of NLRP3 Inflammasome features and association with immune microenvironment in Crohn’s disease
por: Wu, Huihuan, et al.
Publicado: (2023)

Development and validation of a novel ubiquitination-related gene prognostic signature based on tumor microenvironment for colon cancer
por: Huang, Baoyi, et al.
Publicado: (2022)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

Identification of energy metabolism-related biomarkers for risk prediction of heart failure patients using random forest algorithm
por: Chen, Hao, et al.
Publicado: (2022)

Stem cells and exosomes: promising candidates for necrotizing enterocolitis therapy
por: Zeng, Ruijie, et al.
Publicado: (2021)

Association between cardiovascular risk factors and colorectal cancer: A systematic review and meta-analysis of prospective cohort studies
por: Zhang, Chen, et al.
Publicado: (2021)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme
por: Fawzy, Manal S., et al.
Publicado: (2018)

Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme
por: Sun, Ruohan, et al.
Publicado: (2021)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Chromosomal Instability and Phosphoinositide Pathway Gene Signatures in Glioblastoma Multiforme
por: Waugh, Mark G.
Publicado: (2014)

miR-340 suppresses glioblastoma multiforme
por: Huang, Daquan, et al.
Publicado: (2015)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Investigating Causality and Shared Genetic Architecture between Neurodegenerative Disorders and Inflammatory Bowel Disease
por: Zeng, Ruijie, et al.
Publicado: (2023)

A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer
por: Zhang, Cong, et al.
Publicado: (2022)

Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2016)

A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling
por: Guo, Xiao-Yu, et al.
Publicado: (2021)

Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme
por: Zheng, Shuhua, et al.
Publicado: (2021)

Investigating the Mechanisms of Bisdemethoxycurcumin in Ulcerative Colitis: Network Pharmacology and Experimental Verification
por: Wu, Huihuan, et al.
Publicado: (2022)

Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer
por: Zhuo, Zewei, et al.
Publicado: (2022)

Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme
por: Cai, Xiaomin, et al.
Publicado: (2022)

Rho GTPase signaling in rheumatic diseases
por: Zeng, Ruijie, et al.
Publicado: (2021)

Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
por: Chou, Shang-Yu, et al.
Publicado: (2018)

A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme
por: Zhao, Jingwei, et al.
Publicado: (2019)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme
por: Yu, Ziye, et al.
Publicado: (2022)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
por: Xie, Pan, et al.
Publicado: (2022)

BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
por: Reithmeier, Thomas, et al.
Publicado: (2010)

Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme
por: Griguer, Corinne E., et al.
Publicado: (2013)

TSPAN4 is a prognostic and immune target in Glioblastoma multiforme
por: Zheng, Yue, et al.
Publicado: (2023)

Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme
por: Li, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5dvgval24ttihvgnc6qc18houq